![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: KIF13B |
Gene summary for KIF13B |
![]() |
Gene information | Species | Human | Gene symbol | KIF13B | Gene ID | 23303 |
Gene name | kinesin family member 13B | |
Gene Alias | GAKIN | |
Cytomap | 8p12 | |
Gene Type | protein-coding | GO ID | GO:0000902 | UniProtAcc | Q9NQT8 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
23303 | KIF13B | HTA11_3410_2000001011 | Human | Colorectum | AD | 4.05e-27 | -7.70e-01 | 0.0155 |
23303 | KIF13B | HTA11_2951_2000001011 | Human | Colorectum | AD | 1.20e-02 | -7.14e-01 | 0.0216 |
23303 | KIF13B | HTA11_347_2000001011 | Human | Colorectum | AD | 7.81e-04 | 3.69e-01 | -0.1954 |
23303 | KIF13B | HTA11_2992_2000001011 | Human | Colorectum | SER | 5.23e-04 | -3.72e-01 | -0.1706 |
23303 | KIF13B | HTA11_866_3004761011 | Human | Colorectum | AD | 8.10e-17 | -6.59e-01 | 0.096 |
23303 | KIF13B | HTA11_9408_2000001011 | Human | Colorectum | AD | 4.06e-03 | -8.33e-01 | 0.0451 |
23303 | KIF13B | HTA11_8622_2000001021 | Human | Colorectum | SER | 1.23e-02 | -7.19e-01 | 0.0528 |
23303 | KIF13B | HTA11_10711_2000001011 | Human | Colorectum | AD | 3.22e-12 | -6.90e-01 | 0.0338 |
23303 | KIF13B | HTA11_7696_3000711011 | Human | Colorectum | AD | 3.07e-21 | -6.31e-01 | 0.0674 |
23303 | KIF13B | HTA11_6818_2000001021 | Human | Colorectum | AD | 9.02e-04 | -5.84e-01 | 0.0588 |
23303 | KIF13B | HTA11_99999970781_79442 | Human | Colorectum | MSS | 4.03e-39 | -7.57e-01 | 0.294 |
23303 | KIF13B | HTA11_99999965104_69814 | Human | Colorectum | MSS | 1.97e-08 | -5.65e-01 | 0.281 |
23303 | KIF13B | HTA11_99999971662_82457 | Human | Colorectum | MSS | 1.56e-29 | -7.35e-01 | 0.3859 |
23303 | KIF13B | HTA11_99999973899_84307 | Human | Colorectum | MSS | 3.51e-05 | -6.43e-01 | 0.2585 |
23303 | KIF13B | HTA11_99999974143_84620 | Human | Colorectum | MSS | 1.99e-05 | -3.72e-01 | 0.3005 |
23303 | KIF13B | F007 | Human | Colorectum | FAP | 4.05e-04 | -4.34e-01 | 0.1176 |
23303 | KIF13B | A002-C-010 | Human | Colorectum | FAP | 9.06e-08 | -4.03e-01 | 0.242 |
23303 | KIF13B | A001-C-207 | Human | Colorectum | FAP | 2.47e-03 | -2.60e-01 | 0.1278 |
23303 | KIF13B | A015-C-203 | Human | Colorectum | FAP | 2.87e-44 | -6.82e-01 | -0.1294 |
23303 | KIF13B | A015-C-204 | Human | Colorectum | FAP | 3.21e-06 | -4.41e-01 | -0.0228 |
Page: 1 2 3 4 5 6 7 8 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00109759 | Prostate | BPH | regulation of neuron projection development | 118/3107 | 445/18723 | 5.85e-08 | 1.57e-06 | 118 |
GO:00615649 | Prostate | BPH | axon development | 111/3107 | 467/18723 | 3.51e-05 | 3.88e-04 | 111 |
GO:00074099 | Prostate | BPH | axonogenesis | 98/3107 | 418/18723 | 1.68e-04 | 1.45e-03 | 98 |
GO:004211010 | Prostate | BPH | T cell activation | 111/3107 | 487/18723 | 2.11e-04 | 1.72e-03 | 111 |
GO:00507706 | Prostate | BPH | regulation of axonogenesis | 39/3107 | 154/18723 | 3.65e-03 | 1.85e-02 | 39 |
GO:000660519 | Prostate | Tumor | protein targeting | 109/3246 | 314/18723 | 6.11e-14 | 7.30e-12 | 109 |
GO:001097514 | Prostate | Tumor | regulation of neuron projection development | 115/3246 | 445/18723 | 3.34e-06 | 5.44e-05 | 115 |
GO:006156413 | Prostate | Tumor | axon development | 113/3246 | 467/18723 | 8.86e-05 | 8.74e-04 | 113 |
GO:004211015 | Prostate | Tumor | T cell activation | 117/3246 | 487/18723 | 9.22e-05 | 9.05e-04 | 117 |
GO:000740913 | Prostate | Tumor | axonogenesis | 100/3246 | 418/18723 | 3.38e-04 | 2.70e-03 | 100 |
GO:0042110 | Stomach | GC | T cell activation | 53/1159 | 487/18723 | 4.56e-05 | 1.10e-03 | 53 |
GO:00066056 | Stomach | GC | protein targeting | 34/1159 | 314/18723 | 1.09e-03 | 1.27e-02 | 34 |
GO:00421101 | Stomach | CAG with IM | T cell activation | 49/1050 | 487/18723 | 5.44e-05 | 1.37e-03 | 49 |
GO:000660511 | Stomach | CAG with IM | protein targeting | 33/1050 | 314/18723 | 3.98e-04 | 6.38e-03 | 33 |
GO:00421102 | Stomach | CSG | T cell activation | 48/1034 | 487/18723 | 7.39e-05 | 1.78e-03 | 48 |
GO:000660521 | Stomach | CSG | protein targeting | 33/1034 | 314/18723 | 3.03e-04 | 5.20e-03 | 33 |
GO:0006605113 | Thyroid | PTC | protein targeting | 180/5968 | 314/18723 | 6.81e-21 | 1.19e-18 | 180 |
GO:0010975110 | Thyroid | PTC | regulation of neuron projection development | 194/5968 | 445/18723 | 1.05e-07 | 2.08e-06 | 194 |
GO:006156419 | Thyroid | PTC | axon development | 199/5968 | 467/18723 | 5.27e-07 | 8.53e-06 | 199 |
GO:000740918 | Thyroid | PTC | axonogenesis | 178/5968 | 418/18723 | 2.17e-06 | 2.91e-05 | 178 |
Page: 1 2 3 4 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa048144 | Endometrium | AEH | Motor proteins | 42/1197 | 193/8465 | 2.41e-03 | 1.42e-02 | 1.04e-02 | 42 |
hsa0481411 | Endometrium | AEH | Motor proteins | 42/1197 | 193/8465 | 2.41e-03 | 1.42e-02 | 1.04e-02 | 42 |
hsa048142 | Endometrium | EEC | Motor proteins | 42/1237 | 193/8465 | 4.43e-03 | 2.39e-02 | 1.78e-02 | 42 |
hsa048143 | Endometrium | EEC | Motor proteins | 42/1237 | 193/8465 | 4.43e-03 | 2.39e-02 | 1.78e-02 | 42 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
KIF13B | SNV | Missense_Mutation | novel | c.1851N>T | p.Gln617His | p.Q617H | Q9NQT8 | protein_coding | deleterious(0.03) | benign(0.141) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
KIF13B | SNV | Missense_Mutation | novel | c.2320G>A | p.Glu774Lys | p.E774K | Q9NQT8 | protein_coding | tolerated(0.54) | benign(0.062) | TCGA-BH-A0B0-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | CR |
KIF13B | SNV | Missense_Mutation | rs759564273 | c.3275N>A | p.Arg1092His | p.R1092H | Q9NQT8 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-D8-A1JE-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamicin | SD |
KIF13B | SNV | Missense_Mutation | rs753292093 | c.2935N>T | p.Arg979Trp | p.R979W | Q9NQT8 | protein_coding | deleterious(0.01) | probably_damaging(0.982) | TCGA-E9-A1NG-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | letrozole | SD |
KIF13B | SNV | Missense_Mutation | novel | c.340A>G | p.Met114Val | p.M114V | Q9NQT8 | protein_coding | deleterious(0) | probably_damaging(0.953) | TCGA-EW-A2FV-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | docetaxel | SD |
KIF13B | insertion | In_Frame_Ins | novel | c.1235_1236insTCTTTCAAAATCTATTTCTGACAG | p.Glu412delinsAspLeuSerLysSerIleSerAspArg | p.E412delinsDLSKSISDR | Q9NQT8 | protein_coding | TCGA-A2-A04V-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cytoxan | PD | ||
KIF13B | insertion | Nonsense_Mutation | novel | c.4135_4136insTACATGGGGTTGTTTCATAACAGTGG | p.Ser1379IlefsTer7 | p.S1379Ifs*7 | Q9NQT8 | protein_coding | TCGA-AN-A03X-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
KIF13B | insertion | Frame_Shift_Ins | novel | c.4133_4134insTGGTGTCCATGCGTCA | p.Arg1378SerfsTer64 | p.R1378Sfs*64 | Q9NQT8 | protein_coding | TCGA-AN-A03X-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
KIF13B | insertion | Nonsense_Mutation | novel | c.4147_4148insAAGGCGGATAACGTCTCATTTATTCAGAAAATGA | p.Pro1383GlnfsTer4 | p.P1383Qfs*4 | Q9NQT8 | protein_coding | TCGA-BH-A0B1-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Chemotherapy | adriamycin | SD | ||
KIF13B | SNV | Missense_Mutation | rs192432763 | c.5374N>A | p.Ala1792Thr | p.A1792T | Q9NQT8 | protein_coding | tolerated(0.3) | benign(0.009) | TCGA-EA-A3HS-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |